[43] The available evidence suggests that repeated early frequent treatment of central retinal vein occlusion with macular edema (ME) with the anti-VEGF agents ranibizumab, bevacizumab or ...

[46] The study also showed that CRVO treatment with an anti-VEGF agent used on a monthly basis for 6 months followed by PRN produces significantly better results in all end points compared with sham.